On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
ThursdayMar 02, 2017 3:34 pm

India Globalization Capital, Inc. (NYSE MKT: IGC) Targets Cannabis-Based Pharmaceuticals

India Globalization Capital, Inc. (NYSE MKT: IGC) is a company in transition, now targeting pharmaceutical development in the U.S., while curtailing other businesses such as electronics trading in Hong Kong. IGC long-term plans are to establish and extend its development of phytocannabinoid-based pharmaceutical products to treat diseases such as epilepsy and cachexia. The company expects to file more patents and develop additional intellectual property in the health care industry. In the U.S., IGC develops phytocannabinoid-based treatments for epilepsy, seizures and cachexia. The goal in 2017, per CEO Ram Mukunda, is for the company to expand its cannabis-based portfolio, indicating that…

Continue Reading

ThursdayMar 02, 2017 1:49 pm

Pressure BioSciences, Inc. (PBIO) Receives New Instrument Award from Corporate America News Magazine

On Wednesday, Pressure BioSciences, Inc. (OTCQB: PBIO) announced that it has received the award for 'Best New Instrument For Sample Preparation 2017' from Corporate America News (http://nnw.fm/D04Mx) for its Barocycler 2320Extreme. The unit is the most recent product added to PBIO’s Barocycler line. It is a smaller device designed for preparing protein samples for review. It is sold to the life science market, which is valued at roughly $6 billion, according to industry data. Pressure BioSciences, Inc. develops and sells laboratory instrumentation. It manufactures products in static and alternating pressure. The company says it has installed more than 250 of…

Continue Reading

ThursdayMar 02, 2017 1:01 pm

Axim Biotechnologies (AXIM) Boosts Billion-Dollar Brand Portfolio with Launch of CanChew Plus™

Now that production of its next generation award-winning controlled-release cannabidiol (CBD) functional chewing gum, CanChew Plus™, has kicked off, Axim Biotechnologies (OTCQB: AXIM) has boosted its diverse billion-dollar product portfolio with another strong growth brand. With so many golden eggs in its brand basket, the company is expecting strong top line growth in the near future. Current revenue projections show AXIM could soon earn the rarified rank of unicorn. AXIM is looking ahead to a bright future with an uplisting to either the NYSE or NASDAQ. The company’s strong sales projections are built on a number of factors. The company’s…

Continue Reading

ThursdayMar 02, 2017 9:13 am

SinglePoint, Inc. (SING) Banking on Greener Pastures

SinglePoint, Inc. (OTC: SING) has a considerable stake in the state of the legal cannabis industry. Among other things, SinglePoint is a holding company for SingleSeed, a company that provides payment services, solutions, and support for the cannabis industry. Working in tandem, SinglePoint and SingleSeed share resources and offer non-cash payment solutions, such as: Pay by Text solutions that allow customers to pay for products using their mobile phones; point of sale terminals that provide customers the convenience of using debit/credit cards right at checkout; text mobile marketing solutions; and text message marketing. SingleSeed exists to inform and educate shopkeepers…

Continue Reading

WednesdayMar 01, 2017 2:15 pm

CytoDyn Inc.’s (CYDY) PRO 140 is One of the Most Promising Monoclonal Antibody Therapies

New forms of treatment based on monoclonal antibodies show a lot of promise for human immunodeficiency virus patients with drug resistance or limited treatment options, according to HIV/AIDS researchers at this year’s edition of the Conference on Retroviruses and Opportunistic Infections (CROI 2017), which was held last month in Seattle (http://nnw.fm/Co5Ma). Researchers focused on two monoclonal antibody therapies – PRO 140 from CytoDyn Inc. (OTCQB: CYDY) and Ibalizumab from TaiMed Biologics, both of which have shown impressive results during clinical trials as long-acting therapies for HIV patients with limited options because of HIV drug resistance. PRO 140 is currently in two…

Continue Reading

WednesdayMar 01, 2017 1:16 pm

National Waste Management Holdings, Inc. (NWMH) is Increasing Shareholder Value with Roll-Up Strategy

With over 40 years of relevant industry experience, National Waste Management Holdings, Inc. (OTC: NWMH) is on a roll. The company continues to execute a roll-up strategy that is paying huge dividends. Since 2014, NWMH has executed five M&A transactions, which have resulted in an increased customer base, a wider menu of services and a bigger top line. Now, the company is focused on increasing shareholder value by squeezing synergies from those acquisitions. NWMH’s roll-up strategy took off on June 16, 2014, after a reverse merger with Sand/Land of Florida Enterprises, Inc. (“Sandland”), which then became a wholly-owned subsidiary of…

Continue Reading

WednesdayMar 01, 2017 12:28 pm

PotNetwork Holdings, Inc. (POTN) Creating the Highest Quality CBD Oil through Supercritical CO2 Extraction Process

Despite the release of many studies, there is still a lot of confusion surrounding cannabidiol, or CBD. CBD is one of over 85 cannabinoids present in the cannabis plant, and, unlike THC, it interacts with our naturally occurring systems without being psychotropic, which means it doesn’t make a person “high”. In the eyes of many, it is thought to be a safer option while offering numerous health benefits. CBD oil has been shown to help treat anxiety, chronic pain, and diseases such as Crohn's, cancer, and Parkinson's, among others. There are a number of types of hemp CBD oil products,…

Continue Reading

WednesdayMar 01, 2017 11:37 am

ChineseInvestors.com, Inc. (CIIX) Set to Capitalize On Growing Cannabis Industry

Cannabis has been used for thousands of years as a form of natural remedy. But, over time, the possession of marijuana was made illegal in many countries, until now. Most recently, a new movement has taken place whereby both the medical and recreational use of cannabis has been legalized across certain states in the U.S. and a number of countries. The marijuana industry is proving to be important in more ways than one, with Forbes stating that “A new report from New Frontier Data projects that by 2020 the legal cannabis market will create more than a quarter of a…

Continue Reading

WednesdayMar 01, 2017 11:10 am

OurCrowd Qure Leads DarioHealth Corp. (NASDAQ: DRIO) Private Placement with $2.5 Million of $5.1 Million Total

DarioHealth Corp. (NASDAQ: DRIO), a company focused on digital and mobile health and targeting diabetes monitoring, received on January 12, 2017, a private placement investment of $2.5 million from OurCrowd Qure, a health care fund focused on digital solutions. The funds will be used by DarioHealth Corp. to grow its share in existing markets and to expand into new ones, such as Germany. The total private placement is $5.1 million (http://nnw.fm/r5LCo), the company said, of which $2 million will be closed upon future shareholder approval, per NASDAQ rules. DarioHealth Corp., based in Jerusalem and Boston, manufactures a platform for smart…

Continue Reading

WednesdayMar 01, 2017 8:30 am

“Greater Enforcement” of Federal Laws would have Mixed Impact in Cannabis Industry

The White House struck a chord with the marijuana industry last week when press secretary Sean Spicer said the Department of Justice is likely to enforce federal marijuana laws in states that have legalized recreational pot. While the prevailing mood is disappointment among the broader marijuana/cannabis industry, reactions and impacts are mixed among businesses like Singlepoint, Inc. (SING) (SING Profile), Medical Marijuana, Inc. (MJNA), Terra Tech Corp. (TRTC) and Marijuana Company of America Inc. (MCOA). SinglePoint, Inc. (SING) is building an acquisition-based cannabis business focused on high-potential targets that service the cannabis industry rather than those that deal directly with…

Continue Reading

Contact us: 212.418.1217